The landscape of dementia diagnosis has progressed considerably with the advent of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology a long time just before indications emerge. Even though these technological innovations represent exceptional progress in know